- The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse eventsJ P Leombruno
University of Toronto, Department of Pharmaceutical Sciences, Toronto, Ontario, Canada
Ann Rheum Dis 68:1136-45. 2009..To evaluate the safety of biological treatments for rheumatoid arthritis (RA) using results from randomised controlled trials (RCT)...
- Hospitalization and surgical rates in patients with Crohn's disease treated with infliximab: a matched analysisJohn Paul Leombruno
Department of Pharmaceutical Sciences, University of Toronto, Toronto, ON, Canada
Pharmacoepidemiol Drug Saf 20:838-48. 2011..These interventions account for most of the direct costs of the disease. We sought to explore the association between infliximab use and CD-related surgery and hospitalizations...